Bill Haddad - Spark Newswire

1 minute read

General

Kimco Realty Corporation Announces Holding Company Reorganization

Today, 6:12 PM

Kimco Realty® (NYSE:KIM) (the "Company") today announced that it intends to complete a holding company reorganization (the "Reorganization"), which would restructure the Company as an Umbrella

KIM

1 minute read

Innovative Solutions Q4 EPS $0.09, Same YoY, Sales $7.30M Up From $6.87M YoY

By Bill Haddad

Today, 6:12 PM

Innovative Solutions (NASDAQ:ISSC) reported quarterly earnings of $0.09 per share. This is unchanged from the same period last year. The company reported $7.30 million in sales this quarter. This is a 6.21 percent

ISSC

1 minute read

Federal Reserve

FOMC Press Conference To Begin At 2:30 p.m. ET (Livestream Link)

By Bill Haddad

Today, 6:12 PM

https://www.youtube.com/watch?v=jyNip5vFBTQ

SPY

1 minute read

Sen. Warren Earlier Unveiled Bill To Address Money Laundering In Crypto

By Bill Haddad

Today, 6:12 PM

https://www.cnn.com/2022/12/14/business/elizabeth-warren-bipartisan-crypto-crackdown/index.html?utm_medium=social&utm_source=twCNN&utm_term=link&utm_content=2022-12-14T11%3A54%3A07

BTC

1 minute read

Delta Air Lines CEO Says Unmet Demand Is Going To Stay Around For Quite An Extended Period Of Time

By Bill Haddad

Today, 6:12 PM

-Reuters

DAL

1 minute read

General

Microsoft And Viasat Announce Collaboration Through Microsoft Airband Initiative

By Bill Haddad

Today, 6:12 PM

REDMOND, Wash., Dec. 14, 2022 /PRNewswire/ -- On Wednesday, Microsoft Corp. (NASDAQ:MSFT) and Viasat (NASDAQ:VSAT) announced a new partnership to help deliver internet access to 10 million people

MSFT

1 minute read

Urica Therapeutics Expands Exclusive License Agreement With Fuji Yakuhin Co. Ltd. To Develop Dotinurad In Additional Territories Including Turkey, Middle East And North Africa

By Bill Haddad

Today, 6:12 PM

Urica Therapeutics, Inc. ("Urica" or the "Company") (formerly known as UR-1 Therapeutics, Inc.), a Fortress Biotech, Inc. (NASDAQ:FBIO) ("Fortress") subsidiary company focused on the

FBIO

1 minute read

Kymera Announces Results From Phase 1 Clinical Trial Evaluating KT-474 In Patients With HS And AD And Sanofi’s Decision To Advance KT-474 Into Phase 2 Clinical Trials

By Bill Haddad

Today, 6:12 PM

KT-474 Phase 1 clinical data in HS and AD patients demonstrate robust IRAK4 knockdown in blood and active skin lesions and systemic suppression of proinflammatory cytokines and chemokines with a favorable safety

KYMR

1 minute read

Avidity Announces AOC 1001 Phase 1/2 MARINA Data Demonstrating Successful Targeted Delivery Of RNA to Muscle

By Bill Haddad

Today, 6:12 PM

AOC 1001 delivered siRNA to skeletal muscle and produced meaningful DMPK reduction in 100% of participants with a 45% mean reduction in DMPK after a single dose of 1 mg/kg or two doses of 2 mg/kg AOC

RNA

1 minute read

Germany Calls For Global Regulation Of Crypto Industry

By Bill Haddad

Today, 6:12 PM

-Bloomberg

BTC